TY - JOUR
T1 - Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders
AU - Hayes-Lattin, Brandon
AU - Maziarz, Richard T.
PY - 2004/4
Y1 - 2004/4
N2 - Invasive fungal infections contribute to the morbidity and mortality of immunosuppressed patients treated for hematologic malignancy and those undergoing hematopoietic cell transplantation. After years of limited advances, the management of fungal infections in these patients is now rapidly evolving. In this update, we will outline changes in the epidemiology of invasive fungal infections, discuss current issues in diagnosis and susceptibility testing, and review the current classes of antifungal drugs, focusing on newly licensed therapies. Data on antifungal prophylaxis, empiric therapy, and treatment of documented invasive fungal infections including single agents and combinations with newly licensed agents will be reviewed with emphasis on their impact on patients with hematologic malignancies.
AB - Invasive fungal infections contribute to the morbidity and mortality of immunosuppressed patients treated for hematologic malignancy and those undergoing hematopoietic cell transplantation. After years of limited advances, the management of fungal infections in these patients is now rapidly evolving. In this update, we will outline changes in the epidemiology of invasive fungal infections, discuss current issues in diagnosis and susceptibility testing, and review the current classes of antifungal drugs, focusing on newly licensed therapies. Data on antifungal prophylaxis, empiric therapy, and treatment of documented invasive fungal infections including single agents and combinations with newly licensed agents will be reviewed with emphasis on their impact on patients with hematologic malignancies.
KW - Bone marrow transplantation
KW - Leukemia lymphoma
KW - Mycoses
KW - Neutropenia
KW - Opportunistic infection
UR - http://www.scopus.com/inward/record.url?scp=1342344863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1342344863&partnerID=8YFLogxK
U2 - 10.1080/10428190310001625719
DO - 10.1080/10428190310001625719
M3 - Review article
C2 - 15160938
AN - SCOPUS:1342344863
SN - 1042-8194
VL - 45
SP - 669
EP - 680
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 4
ER -